226 related articles for article (PubMed ID: 24376736)
1. Association between CTLA-4 60G/A and -1661A/G polymorphisms and the risk of cancers: a meta-analysis.
Yan Q; Chen P; Lu A; Zhao P; Gu A
PLoS One; 2013; 8(12):e83710. PubMed ID: 24376736
[TBL] [Abstract][Full Text] [Related]
2. Association between cytotoxic T lymphocyte antigen-4 +49A/G, -1722T/C, and -1661A/G polymorphisms and cancer risk: a meta-analysis.
Geng R; Song F; Yang X; Sun P; Hu J; Zhu C; Zhu B; Fan W
Tumour Biol; 2014 Apr; 35(4):3627-39. PubMed ID: 24307627
[TBL] [Abstract][Full Text] [Related]
3. Associations between the cytotoxic T lymphocyte antigen 4 polymorphisms and risk of bone sarcomas.
Fan C; Zhao X; Xu Z
Tumour Biol; 2015 Jan; 36(1):227-31. PubMed ID: 25230787
[TBL] [Abstract][Full Text] [Related]
4. Association of Cytotoxic T-lymphocyte Antigen-4 Polymorphisms with Malignant Bone Tumor Risk: A Meta-analysis.
Zhang C; Hou WH; Ding XX; Wang X; Zhao H; Han XW; Wang WJ
Asian Pac J Cancer Prev; 2016; 17(8):3785-91. PubMed ID: 27644617
[TBL] [Abstract][Full Text] [Related]
5. [Association between cytotoxic T lymphocyte protein-4 polymorphisms and non-Hodgkin's lymphoma risk: a meta-analysis].
Yi B; Pei Y; Wang C; Jiang Y
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Aug; 32(8):1099-104. PubMed ID: 27412943
[TBL] [Abstract][Full Text] [Related]
6. Association of cytotoxic T lymphocyte antigen-4 +49A/G polymorphism and cancer risk: An updated meta-analysis.
Gao X; Zhang S; Qiao X; Yao Y; Wang L; Dong D; Ma X; Wang T
Cancer Biomark; 2014; 14(4):287-94. PubMed ID: 24934372
[TBL] [Abstract][Full Text] [Related]
7. Meta-analysis of the cytotoxic T-lymphocyte antigen 4 gene +6230G/A polymorphism and cancer risk.
Zhao HY; Duan HX; Gu Y
Clin Transl Oncol; 2014 Oct; 16(10):879-85. PubMed ID: 24493286
[TBL] [Abstract][Full Text] [Related]
8. Association between ATM rs1801516 polymorphism and cancer susceptibility: a meta-analysis involving 12,879 cases and 18,054 controls.
Gu Y; Shi J; Qiu S; Qiao Y; Zhang X; Cheng Y; Liu Y
BMC Cancer; 2018 Nov; 18(1):1060. PubMed ID: 30384829
[TBL] [Abstract][Full Text] [Related]
9. Impacts of CD152 polymorphisms on cervical cancer susceptibility.
Cao S; Zheng L
Pathol Res Pract; 2020 Aug; 216(8):152918. PubMed ID: 32616425
[TBL] [Abstract][Full Text] [Related]
10. A meta-analysis of the association between CTLA-4 genetic polymorphism and susceptibility of asthma.
Zheng Y; Wang H; Luo L; Liao L; You L; Wang J; Li Q
Medicine (Baltimore); 2018 Jul; 97(28):e11380. PubMed ID: 29995780
[TBL] [Abstract][Full Text] [Related]
11. Cytotoxic T-lymphocyte antigen 4 polymorphisms and breast cancer susceptibility: Evidence from a meta-analysis.
Chang HY; Liu CY; Lo YL; Chiou SH; Lu KH; Lee MC; Wang YH
J Chin Med Assoc; 2023 Feb; 86(2):207-219. PubMed ID: 36652567
[TBL] [Abstract][Full Text] [Related]
12. Polymorphisms in the cytotoxic T-lymphocyte antigen 4 gene and acute rejection risk in transplant recipients.
Zhu CL; Huang Q; Liu CH; Xie F
Mol Biol Rep; 2012 Sep; 39(9):8701-8. PubMed ID: 22711308
[TBL] [Abstract][Full Text] [Related]
13. Association between
Zhou C; Gao S; Yuan X; Shu Z; Li S; Sun X; Xiao J; Liu H
Aging (Albany NY); 2021 Aug; 13(15):19397-19414. PubMed ID: 34339393
[TBL] [Abstract][Full Text] [Related]
14. Association between CTLA-4 exon-1 +49A/G polymorphism and systemic lupus erythematosus: an updated analysis.
Chang WW; Zhang L; Yao YS; Su H
Mol Biol Rep; 2012 Sep; 39(9):9159-65. PubMed ID: 22718509
[TBL] [Abstract][Full Text] [Related]
15. CTLA-4 polymorphisms and systemic lupus erythematosus (SLE): a meta-analysis.
Zhai JX; Zou LW; Zhang ZX; Fan WJ; Wang HY; Liu T; Ren Z; Dai RX; Ye D
Mol Biol Rep; 2013 Sep; 40(9):5213-23. PubMed ID: 23922195
[TBL] [Abstract][Full Text] [Related]
16. CTLA-4 +49 A/G Polymorphism and the Risk of Lung Cancer: a Meta-analysis.
Wei Z; Zhang S; Hu J
Zhongguo Fei Ai Za Zhi; 2021 Mar; 24(3):173-181. PubMed ID: 33819967
[TBL] [Abstract][Full Text] [Related]
17. The effect of CTLA-4 A49G polymorphism on rheumatoid arthritis risk: a meta-analysis.
Li G; Shi F; Liu J; Li Y
Diagn Pathol; 2014 Aug; 9():157. PubMed ID: 25128482
[TBL] [Abstract][Full Text] [Related]
18. Significant association between cytotoxic T lymphocyte antigen 4 +49G>A polymorphism and risk of malignant bone tumors.
Yu F; Miao J
Tumour Biol; 2013 Dec; 34(6):3371-5. PubMed ID: 23900675
[TBL] [Abstract][Full Text] [Related]
19. Lack of association between cytotoxic T-lymphocyte antigen-4 -318C/T polymorphism and cancer risk: a meta-analysis of case-control studies.
Xia W; Shi R; Zheng WL; Ma WL
Technol Cancer Res Treat; 2013 Dec; 12(6):565-74. PubMed ID: 23745791
[TBL] [Abstract][Full Text] [Related]
20. Association between CTLA-4 exon-1 +49A>G polymorphism and primary biliary cirrhosis risk: a meta-analysis.
Huang Q; Shao F; Wang C; Qiu LJ; Hu YG; Yu JH
Arch Med Res; 2011 Apr; 42(3):235-8. PubMed ID: 21722820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
